• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimized management in patients with bladder cancer.

作者信息

Babjuk Marek

机构信息

Department of Urology, Hospital Motol and 2 Faculty of Medicine, Charles University, Prague, Czech Republic.

出版信息

Cent European J Urol. 2015;68(1):15-6. doi: 10.5173/ceju.2015.01.e93.

DOI:10.5173/ceju.2015.01.e93
PMID:25914831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4408400/
Abstract
摘要

相似文献

1
Optimized management in patients with bladder cancer.膀胱癌患者的优化管理。
Cent European J Urol. 2015;68(1):15-6. doi: 10.5173/ceju.2015.01.e93.
2
Imaging in Localized Bladder Cancer: Can Current Diagnostic Modalities Provide Accurate Local Tumor Staging?局限性膀胱癌的影像学检查：当前的诊断方法能否准确进行局部肿瘤分期？
Curr Urol Rep. 2019 Nov 28;20(12):82. doi: 10.1007/s11934-019-0948-7.
3
Supporting self-management of radiation-induced bowel and bladder dysfunction in pelvic-cancer rehabilitation: An ethnographic study.支持骨盆癌康复中放射性肠和膀胱功能障碍的自我管理：一项民族志研究。
J Clin Nurs. 2019 Jul;28(13-14):2624-2634. doi: 10.1111/jocn.14849. Epub 2019 Mar 29.
4
[Management of Ta, T1, and in situ bladder carcinoma: what is new?].[Ta期、T1期及原位膀胱癌的管理：有哪些新进展？]
Prog Urol. 2008 May;18 Suppl 5:S94-8. doi: 10.1016/S1166-7087(08)72484-9.
5
A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group.国际膀胱癌组织对非肌肉浸润性膀胱癌管理的现行指南和最佳实践建议综述。
J Urol. 2011 Dec;186(6):2158-67. doi: 10.1016/j.juro.2011.07.076. Epub 2011 Oct 19.
6
Bladder cancer: overview and disease management. Part 1: non-muscle-invasive bladder cancer.膀胱癌：概述与疾病管理。第1部分：非肌层浸润性膀胱癌。
Br J Nurs. 2018 May 10;27(9):S27-S37. doi: 10.12968/bjon.2018.27.9.S27.
7
Management of muscle-invasive bladder cancer in Victoria, 1990-1995.1990 - 1995年维多利亚州肌层浸润性膀胱癌的管理
ANZ J Surg. 2006 Mar;76(3):113-9. doi: 10.1111/j.1445-2197.2006.03665.x.
8
Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer.鉴定一个九基因panel作为肌肉浸润性膀胱癌复发的预后指标。
J Surg Oncol. 2019 Jun;119(8):1145-1154. doi: 10.1002/jso.25446. Epub 2019 Mar 18.
9
The dosimetric impact of heterogeneity corrections in high-dose-rate ¹⁹²Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans.高剂量率¹⁹²Ir近距离放射治疗宫颈癌中不均匀性校正的剂量学影响：传统A点和体积优化计划的研究
Brachytherapy. 2012 Nov-Dec;11(6):515-20. doi: 10.1016/j.brachy.2012.01.011. Epub 2012 Mar 3.
10
Surgical management of bladder carcinoma.膀胱癌的外科治疗
Cancer Control. 2002 Jul-Aug;9(4):284-92. doi: 10.1177/107327480200900403.

引用本文的文献

1
Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer.评估阿帕喹酮（E09，Qapzola™）膀胱内灌注治疗低危非肌层浸润性膀胱癌经尿道膀胱肿瘤切除术后疗效的双盲、随机、安慰剂对照研究。
Bladder Cancer. 2018 Jul 30;4(3):293-301. doi: 10.3233/BLC-180166.
2
Liquid biopsies for surveillance and monitoring treatment response of bladder cancer.用于膀胱癌监测和治疗反应监测的液体活检
Ann Transl Med. 2016 Oct;4(19):379. doi: 10.21037/atm.2016.08.27.
3
Author'S reply.作者回复。
Cent European J Urol. 2015;68(1):17. doi: 10.5173/ceju.2015.01.r95.

本文引用的文献

1
Timing of radical cystectomy in Central Europe - multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients.中欧地区根治性膀胱切除术的时机——关于影响膀胱癌患者从诊断到根治性治疗时间的因素的多中心研究
Cent European J Urol. 2015;68(1):9-14. doi: 10.5173/ceju.2015.01.444. Epub 2014 Dec 17.
2
Transurethral bladder tumor resection can cause seeding of cancer cells into the bloodstream.经尿道膀胱肿瘤切除术可导致癌细胞播散到血液中。
J Urol. 2015 Jan;193(1):53-7. doi: 10.1016/j.juro.2014.06.083. Epub 2014 Jul 1.
3
Care transitions between hospitals are associated with treatment delay for patients with muscle invasive bladder cancer.医院之间的护理过渡与肌层浸润性膀胱癌患者的治疗延迟有关。
J Urol. 2014 Nov;192(5):1349-54. doi: 10.1016/j.juro.2014.05.027. Epub 2014 May 14.
4
Longer wait times increase overall mortality in patients with bladder cancer.更长的等待时间会增加膀胱癌患者的总体死亡率。
J Urol. 2009 Oct;182(4):1318-24. doi: 10.1016/j.juro.2009.06.041. Epub 2009 Aug 14.
5
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.根治性膀胱切除术延迟超过3个月与较差的临床结果无关。
BJU Int. 2007 Nov;100(5):1015-20. doi: 10.1111/j.1464-410X.2007.07132.x. Epub 2007 Sep 3.
6
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.治疗模式的转变可能会提高高危浅表性膀胱癌患者的生存率。
J Urol. 2007 Apr;177(4):1283-6; discussion 1286. doi: 10.1016/j.juro.2006.11.090.